With respect to sex effects, prior studies have reported higher DAT availability in female.[21,35] This study showed no age difference between patients with AD and healthy controls and only enrolled male subjects, thus abolishing age and sex as confounding factors in this study. This evidence concerns the gene SLC6A3 and Alzheimer disease.